Michael (Mick) D. Murray, PharmD, MPH
Distinguished Professor of Pharmacy and Endowed Chair of Medication Safety, Purdue University College of Pharmacy
Research Scientist, Indiana University Center for Health Services and Outcomes Research
Research Scientist, William M. Tierney Center for Health Services Research, Regenstrief Institute, Inc.
Adjunct Professor, Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine
Dr. Murray is appointed Distinguished Professor of Pharmacy in the Purdue University College of Pharmacy where he holds the Endowed Chair of Medication Safety. He also is appointed Adjunct Professor of Medicine in General Internal Medicine and Geriatrics at the Indiana University School of Medicine.
Dr. Murray’s research interests include developing pharmacy services to improve drug therapy in older adults with chronic disorders, medication safety, improving the quality of health of low-income minority people, and pharmacoepidemiology using large population computer databases.
Dr. Murray’s collaborations include Chair for both the Patient Safety and Informatics Course Development Committee and the Medication Safety Strategic Priorities Taskforce at Purdue School of Pharmacy. He supports the PhRMA Foundation mission to develop young scientists in pharmaceutical research and education by serving on the Expert Panel of the Comparative Effectiveness Research in Health Professional Curricula and on the Comparative Effectiveness Research Award in Excellence Review Committee. Dr. Murray is a member of the External Advisory Committee for the Clinical Pharmacoepidemiology Training Program at the University of Pennsylvania, funded by the National Institute of General Medical Sciences in the U.S. National Institutes of Health. He is a Fellow of the International Society for Pharmacoepidemiology and a member of the Clinical Effectiveness Research Innovation Collaborative (CERIC), Institute of Medicine, National Academy of Sciences, Washington, DC.
I. Regenstrief Foundation (2011-2015)
An active drug safety surveillance and quality improvement program utilizing Indiana Network for Patient Care data.
|Selected Publications|||||Go To PubMed List >>|
1: Chin J, Madison A, Gao X, Graumlich JF, Conner-Garcia T, Murray MD, Stine-Morrow EA, Morrow DG. Cognition and Health Literacy in Older Adults' Recallof Self-Care Information. Gerontologist. 2017 Apr 1;57(2):261-268. doi:10.1093/geront/gnv091. PubMed PMID: 26209450.
2: Chin J, Moeller DD, Johnson J, Duwe EA, Graumlich JF, Murray MD, Morrow DG. A Multi-faceted Approach to Promote Comprehension of Online Health InformationAmong Older Adults. Gerontologist. 2017 Mar 10. doi: 10.1093/geront/gnw254. [Epub ahead of print] PubMed PMID: 28329840.
3: Aljadhey H, Mahmoud MA, Ahmed Y, Sultana R, Zouein S, Alshanawani S, Mayet A, Alshaikh MK, Kalagi N, Al Tawil E, El Kinge AR, Arwadi A, Alyahya M, Murray MD, Bates D. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study. BMJ Open. 2016 Jul12;6(7):e010831. doi: 10.1136/bmjopen-2015-010831. PubMed PMID: 27406640; PubMed Central PMCID: PMC4947792.
4: Overhage JM, Gandhi TK, Hope C, Seger AC, Murray MD, Orav EJ, Bates DW.Ambulatory Computerized Prescribing and Preventable Adverse Drug Events. J Patient Saf. 2016 Jun;12(2):69-74. doi: 10.1097/PTS.0000000000000194. PubMedPMID: 26001546.
5: Dixon BE, Whipple EC, Lajiness JM, Murray MD. Utilizing an integrated infrastructure for outcomes research: a systematic review. Health Info Libr J.2016 Mar;33(1):7-32. doi: 10.1111/hir.12127. Epub 2015 Dec 7. Review. PubMed PMID: 26639793.
6: Tu W, Decker BS, He Z, Erdel BL, Eckert GJ, Hellman RN, Murray MD, Oates JA, Pratt JH. Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension. J Gen Intern Med. 2016Jan;31(1):30-6. doi: 10.1007/s11606-015-3469-1. PubMed PMID: 26194642; PubMedCentral PMCID: PMC4700022.
7: Kim KM, Murray MD, Tu W, Robarge J, Ding Y, Brater DC, Flockhart DA. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure. Eur J Clin Pharmacol. 2012 Nov; 68(11):1483-91. doi: 10.1007/s00228-012-1280-z. Epub 2012 Apr 29. PubMed PMID: 22543981.
8: Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure inpatients with hypertension. BMC Cardiovasc Disord. 2012 Oct 24;12:93. doi:10.1186/1471-2261-12-93. PubMed PMID: 23092442; PubMed Central PMCID: PMC3502533.
9: Noureldin M, Plake KS, Morrow DG, Tu W, Wu J, Murray MD. Effect of healthliteracy on drug adherence in patients with heart failure. Pharmacotherapy. 2012 Sep;32(9):819-26. doi: 10.1002/j.1875-9114.2012.01109.x. Epub 2012 Jun 28. PubMedPMID: 22744746.
10: Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother. 2012 Jun;10(3):165-77. doi:10.1016/j.amjopharm.2012.04.004. Review. PubMed PMID: 22657941.